{"id":391474,"date":"2014-12-18T00:00:00","date_gmt":"2014-12-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/pcorim0714-biopharma-systemic-lupus-erythematosus-pharmacor-g7-2014\/"},"modified":"2026-03-31T09:04:15","modified_gmt":"2026-03-31T09:04:15","slug":"pcorim0714-biopharma-systemic-lupus-erythematosus-pharmacor-g7-2014","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/pcorim0714-biopharma-systemic-lupus-erythematosus-pharmacor-g7-2014\/","title":{"rendered":"Systemic Lupus Erythematosus | Pharmacor | G7 | 2014"},"content":{"rendered":"<p>Historically, developers of systemic lupus erythematosus (SLE) drugs faced formidable challenges: drug development and regulatory hurdles, a small and heterogeneous population, and a multiplicity of manifestations. Recent positive clinical trial results and the regulatory approval of belimumab (GlaxoSmithKline\u2019s Benlysta)\u2014the first new agent in 50 years\u2014have lowered some development hurdles, and a growing list of emerging agents has ushered in a new era of SLE drug development. We forecast that sales of SLE therapies will increase approximately threefold during our 2013-2023 forecast period, driven largely by the entry and uptake of premium-priced biologics.<\/p>\n","protected":false},"template":"","class_list":["post-391474","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-systemic-lupus-erythematosus","biopharma-geography-us","biopharma-date-574"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391474\/revisions"}],"predecessor-version":[{"id":394597,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391474\/revisions\/394597"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}